Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noradrenergic basis of Parkinson's tremor: propranolol and fMRI
2016-004629-18Phase 3Completed
- Sponsor
- Radboud University
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of propranolol in Parkinson's disease (PD), sponsored by Radboud University. Primary endpoint: Change in tremor-related cerebral activity and connectivity (fMRI BOLD signal). Started Jan 2017; status: completed.
02
Drugs
propranolol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2016-004629-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004629-18.